Other intangible assets—net
Vertex Pharmaceuticals Other intangible assets—net decreased by 1.3% to $418.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.1%, from $441.20M to $418.50M. Over 5 years (FY 2020 to FY 2025), Other intangible assets—net shows relatively stable performance with a 1.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase typically signals recent strategic acquisitions or significant investment in R&D and intellectual property, while a decrease reflects ongoing amortization or potential impairment.
Detailed definition
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software...
Peer comparison
High in semiconductor and tech firms due to heavy reliance on patent portfolios and acquired technology.
non_current_assets_intangible_assets_net_excluding_goodwillHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $400.00M | $400.00M | $400.00M | $400.00M | $387.00M | $603.60M | $603.60M | $603.60M | $603.60M | $603.60M | $839.90M | $834.90M | $837.50M | $831.60M | $825.90M | $441.20M | $435.50M | $429.80M | $424.20M | $418.50M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -3.3% | +56.0% | +0.0% | +0.0% | +0.0% | +0.0% | +39.1% | -0.6% | +0.3% | -0.7% | -0.7% | -46.6% | -1.3% | -1.3% | -1.3% | -1.3% |
| YoY Change | — | — | — | — | -3.3% | +50.9% | +50.9% | +50.9% | +56.0% | +0.0% | +39.1% | +38.3% | +38.8% | +37.8% | -1.7% | -47.2% | -48.0% | -48.3% | -48.6% | -5.1% |
Other intangible assets—net at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's other intangible assets—net?
- Vertex Pharmaceuticals (VRTX) reported other intangible assets—net of $418.50M in Q1 2026.
- How has Vertex Pharmaceuticals's other intangible assets—net changed year-over-year?
- Vertex Pharmaceuticals's other intangible assets—net decreased by 5.1% year-over-year, from $441.20M to $418.50M.
- What is the long-term trend for Vertex Pharmaceuticals's other intangible assets—net?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's other intangible assets—net has grown at a 1.2% compound annual growth rate (CAGR), from $400.00M to $424.20M.
- What does other intangible assets—net mean?
- The value of non-physical assets like patents and intellectual property, excluding goodwill.